Women are cerebral in sex, and men are physical. That’s why men don’t need a reason necessarily for sex. And now, neither do women!
The feminist militants have struck again, demanding to have what men get so easily–sexual pleasure.
The FDA caved, allowing the new drug that supposedly increases the sexual desire in premenopausal women, similar to the effects of Viagra for men.
Women now have their highly controversial pink pill. How sexist is that!
The pill is sold under the brand name Addyi; its chemical name is Filibanserin. Despite arguments that the pill is for the most part ineffective and potentially dangerous, the feminist lobbyists leveled charges of gender bias against the FDA, thus getting the pill approved.
Feminist funded a letter writing campaign called “Even the Score.” They received some of the funding from the drug’s maker, Sprout Pharmaceuticals.
Did SCOTUS make the right decision on medical mandates for large businesses?
The campaign invited visitors to its website and Facebook pages to sign a petition to the FDA and to write their congressman. Among the Congresswomen who pressured the FDA for its approval were Reps. Debbie Wasserman Schultz (D-FL), Chellie Pingree (D-ME), Nita Lowey (D-NY), Louise Slaughter (D-NY) and Rep. Jackie Speier (D-CA).
I guess this drug is about choice. Men have a pill, so why shouldn’t women.
The FDA had resisted approval of the drug because of its poor pre-trial results and its harmful potential effects against women who take it. The drug has been proven to cause dangerously low blood pressure and fainting as one of the side effects, especially when taken with alcohol. The drug also must be taken daily, so women can forget about that glass of wine with their romantic dinner.
One article reported:
“Unlike Viagra, which affects blood flow to the genitals, Addyi is meant to activate sexual impulses in the brain. It is similar to a class of other drugs known as selective serotonin reuptake inhibitors, or SSRI’s, that include antidepressants such as Prozac.
Women who took Addyi in a clinical study had an increase of about one sexually satisfying event per month compared with those taking a placebo. Advocates claim that increase is meaningful. Critics say the small benefit is outweighed by the drug’s risks.
Addyi will come with a prominent “boxed warning” about side effects, including among people with liver impairment or who take Addyi with alcohol or with medicines known as CYP3A4 inhibitors that include certain steroids.”
So men have a noticeable physical problem that causes their inability to perform sex, but for women it’s mental?
Viagra is not covered by insurance, but you can bet that the American taxpayer will pay for Addyi. The estimated copay is $30-$70 per month for America to provide women their sexual pleasure, or at least those who don’t pass out when mixing it with alcohol.
There’s more good news for women. Since the FDA didn’t perform due diligence, women using the drug now have a built-in lawsuit if they pass out for any reason, including lack of interest in their sexual partner.
Government entities like the FDA should be immune to politics. The science to make sure it’s safe isn’t there yet. The pharmaceutical company, activists and politicians who pushed this drug prematurely will all run for cover when women suffer from the side effects. They’ll spin this as further evidence of the War on Women, a war that women and Liberal politicians are waging.